208 related articles for article (PubMed ID: 2971659)
1. Identification of the C3b receptor-binding domain in third component of complement.
Becherer JD; Lambris JD
J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
[TBL] [Abstract][Full Text] [Related]
2. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
3. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
Medof ME; Iida K; Mold C; Nussenzweig V
J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
[TBL] [Abstract][Full Text] [Related]
4. Third component of complement (C3): structural properties in relation to functions.
Bokisch VA; Dierich MP; Mūller-Eberhard HJ
Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
[TBL] [Abstract][Full Text] [Related]
5. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
6. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
[TBL] [Abstract][Full Text] [Related]
7. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
[TBL] [Abstract][Full Text] [Related]
8. Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.
Fries LF; Prince GM; Gaither TA; Frank MM
J Immunol; 1985 Oct; 135(4):2673-9. PubMed ID: 3161945
[TBL] [Abstract][Full Text] [Related]
9. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35).
Oran AE; Isenman DE
J Biol Chem; 1999 Feb; 274(8):5120-30. PubMed ID: 9988761
[TBL] [Abstract][Full Text] [Related]
10. Localization of the conglutinin binding site on the third component of human complement.
Hirani S; Lambris JD; Müller-Eberhard HJ
J Immunol; 1985 Feb; 134(2):1105-9. PubMed ID: 3965568
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.
Huemer HP; Wang Y; Garred P; Koistinen V; Oppermann S
Immunology; 1993 Aug; 79(4):639-47. PubMed ID: 8406590
[TBL] [Abstract][Full Text] [Related]
12. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the properdin-binding site in the third component of complement.
Lambris JD; Alsenz J; Schulz TF; Dierich MP
Biochem J; 1984 Jan; 217(1):323-6. PubMed ID: 6696726
[TBL] [Abstract][Full Text] [Related]
14. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
[TBL] [Abstract][Full Text] [Related]
15. Characterization of tryptic fragments of human complement factor C3.
Eggertsen G; Hellman U; Lundwall A; Folkersen J; Sjöquist J
Mol Immunol; 1985 Aug; 22(8):833-41. PubMed ID: 3930949
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody.
Holers VM; Seya T; Brown E; O'Shea JJ; Atkinson JP
Complement; 1986; 3(2):63-78. PubMed ID: 2945695
[TBL] [Abstract][Full Text] [Related]
17. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
Porteu F; Mir A; Halbwachs-Mecarelli L
Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
[TBL] [Abstract][Full Text] [Related]
18. Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 binding.
Pan Q; Ebanks RO; Isenman DE
J Immunol; 2000 Sep; 165(5):2518-27. PubMed ID: 10946278
[TBL] [Abstract][Full Text] [Related]
19. Phylogeny of the third component of complement, C3: analysis of the conservation of human CR1, CR2, H, and B binding sites, concanavalin A binding sites, and thiolester bond in the C3 from different species.
Alsenz J; Avila D; Huemer HP; Esparza I; Becherer JD; Kinoshita T; Wang Y; Oppermann S; Lambris JD
Dev Comp Immunol; 1992; 16(1):63-76. PubMed ID: 1535601
[TBL] [Abstract][Full Text] [Related]
20. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.
Taniguchi-Sidle A; Isenman DE
J Immunol; 1994 Dec; 153(11):5285-302. PubMed ID: 7963581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
